International Study of Biofield Therapy

Completed

• Conditions: Pain; Depression, Anxiety; Dizziness; Signs and Symptoms

• Registration Number: NCT03994809
• Lead Sponsor: MOA Health Science Foundation

Brief Summary

Participants from 14 different countries received a single session of biofield therapy (Okada Purifying Therapy) lasting 30 minutes or longer from the volunteer practitioners. Before and after the therapy, they reported the severity of physical pain, anxiety/depression, dizziness/palpitation, and overall symptoms. The team compared the effectiveness/safety of biofield therapy between countries and analyzed the factors associated with the outcomes.

Detailed Description

Participants aged 16 or older from 14 different countries (Japan, USA, Argentina, Brazil, Chile, Mexico, Peru, Taiwan, Thai, South Korea, Belgium, France, Portugal, and Spain) received a single session of biofield therapy (Okada Purifying Therapy) lasting 30 minutes or longer from the volunteer practitioners in their country of residence. Before and after the intervention, they reported each severity level of physical pain, anxiety/depression, dizziness/palpitation, and overall symptoms. The team compared the improvement/exacerbation rate of a single session of biofield therapy between the countries, and examined the adjusted odds ratio of the variables associated with the changes in each category of symptoms in a real-world setting.

Study Timeline

• Study Start: 2008-01-01
• Primary Completion: 2010-09-30
• Study Completion: 2010-09-30
• Status Verified: 2019-06
• Study First Submitted: 2019-06-17
• Study First Submitted QC: 2019-06-19
• Last Update Submitted: 2019-06-19
• Study First Posted: 2019-06-21
• Last Update Posted: 2019-06-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 12000

Inclusion Criteria

1. Individuals who agreed to receive a single session of biofield therapy for 30 minutes or longer from the volunteer investigators.
2. Individuals who were able to self-evaluate the change of their symptoms.
3. Individuals who were competent to answer the questionnaires.
4. Individuals who were aged 16 or older.

Exclusion Criteria

• no specific exclusion criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
adjusted odds ratio of the factors associated with the changes in symptoms	Up to one year after all the data were collected.	Logistic regression analyses
improvement/exacerbation rate of symptoms after a single session of biofield therapy	Up to one year after all the data were collected.	The Mann-Whitney test was conducted to compare the improvement/exacerbation rates between countries.